[ad_1]
Firm intends to increase its community of longevity-focused precision drugs facilities within the US and internationally.
Precision drugs firm Human Longevity, Inc. (HLI) has efficiently raised $39.8 million in an “upsized” Collection B financing spherical to additional develop its synthetic intelligence-driven well being danger and suggestion platform, and introduce new applied sciences and companies associated to longevity. Co-founded in 2013 by genomics pioneer Dr J Craig Venter, the corporate’s mission is to increase human well being and efficiency past the standard medical concentrate on treating diseases.
San Francisco-based HLI, which leverages superior applied sciences to increase human lifespan and healthspan, additionally plans to make use of the brand new funding to help world growth of its clinics, with new websites deliberate past its present areas within the US. The corporate, which operates well being evaluation facilities in San Francisco and San Diego, says it expects to open future areas in Europe, Asia, Saudi Arabia, and different GCC international locations.
HLI, which just lately introduced a strategic partnership with the Chopra Foundation, goals to shift healthcare from a reactive strategy to a extra proactive, preventive, and personalised system. By frequently analyzing well being knowledge from its purchasers, the corporate seeks to determine potential well being points early, enabling focused interventions that may lengthen not solely lifespan but in addition the interval of wholesome residing, or healthspan.
Early detection of well being dangers akin to most cancers, heart problems, neurodegenerative issues and metabolic situations permits for well timed intervention, which not solely saves lives however also can assist scale back total healthcare prices. By catching potential well being points earlier than they turn into severe situations, HLI claims its strategy provides the potential for higher well being outcomes and extra environment friendly administration of sources within the healthcare system.
On the core of HLI’s providing is the 100+ Longevity Care program, which is designed to detect early indicators of age-related ailments and supply interventions geared toward rising each healthspan and lifespan. This system makes use of a wide range of instruments to collect well being knowledge, together with complete genome sequencing, superior imaging methods like whole-body and mind MRIs, complete cardiac evaluations, physique composition analyses, superior blood biomarkers, and wearable gadgets. This mix of knowledge and expertise is designed to allow a extremely personalised strategy to well being administration, with the aim of decreasing organic age and stopping illness.
Past its work with its purchasers, HLI can also be targeted on conducting longevity analysis, together with a key study in 2020, which demonstrated how the mixing of whole-genome sequencing, metabolomics, and superior imaging can determine, and assist mitigate, main well being dangers.
The Collection B spherical, which exceeded its preliminary goal, was led by TVM Capital Healthcare and noticed participation from each new and current buyers, together with Panacea Enterprise and Rising Know-how Companions.
{Photograph}: Angelov1/Envato
[ad_2]
Source link
